Covaxin

New Delhi: The Subject Expert Committee (SEC) under the drug regulator on Tuesday said that Hyderabad based Bharat Biotech's Covaxin has shown 77.8 per cent efficacy. According to reports, the company had submitted data from the Phase…

New Delhi: India's indigenous COVID vaccine Covaxin has submitted its phase-3 clinical trial data to WHO on Wednesday, for its authorisation and global approval. Sources state that Covaxin's approval application will be taken up for…

Hyderabad: The Hyderabad-based vaccine maker, Bharat Biotech on Tuesday said that the supply price of Covaxin to the central government at Rs150 per dose is not sustainable in the long run. Bharat Biotech said in a statement that the…

New Delhi: The recruitment for the clinical trial Bharat Biotech's vaccine Covaxin, among children in the age group of 6-12 years will begin at the AIIMS today. This will be followed by the clinical trial of children in the age-group of…

New Delhi: Bharat Biotech has provided adequate data to the satisfaction of India's drug regulator and hence the USFDA’s decision, though respected, won't make any difference in India, said Dr VK Paul Member-Health, Niti Aayog on USFDA…

New Delhi: A day after Prime Minister Narendra Modi announced that the Centre would take over the state procurement quota and provide free jabs to state governments for inoculation of all above the age of 18, the Union Health Ministry…

As the whole nation battles the second wave of COVID-19, COVAXIN-producer Bharat Biotech on Friday issued a statement on the production & supply of COVID-19 vaccines to the states. The manufacturing, testing, release and distribution…

New Delhi: Amid an ongoing struggle to vaccinate all above 18, Bharat Biotech received the approval for phase II and phase III clinical trials of vaccines on children between the age of two and 18 years. In short, India’s drug regulator…

Bhubaneswar: Odisha on Saturday received another 1 lakh doses of Covishield vaccine at Biju Patnaik International Airport here at 2 PM on Saturday. The State government had placed an initial order for 3.77 crore Covishield doses and…

Bhubaneswar: Because of IDCO’s smooth land allotment process and ‘ease of doing business’ reforms, the construction of a vaccine production unit has started at Andharua in Bhubaneswar. The required statutory clearances and permissions have…